Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
BIOA | BioAge Labs, Inc. | Chief Financial Officer | Sep 25, 2024 | |||
COYA | Coya Therapeutics, Inc. | Director | Jan 1, 2024 | |||
GANX | Gain Therapeutics, Inc. | Director | Jun 24, 2024 | |||
NBSE | NeuBase Therapeutics, Inc. | Director | Sep 9, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|